RAPT Therapeutics (RAPT) Assets Average (2020 - 2024)
Historic Assets Average for Therapeutics (RAPT) over the last 5 years, with Q3 2024 value amounting to $117.8 million.
- Therapeutics' Assets Average fell 4395.77% to $117.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $117.8 million, marking a year-over-year decrease of 4395.77%. This contributed to the annual value of $219.8 million for FY2023, which is 544.42% down from last year.
- According to the latest figures from Q3 2024, Therapeutics' Assets Average is $117.8 million, which was down 4395.77% from $141.5 million recorded in Q2 2024.
- Therapeutics' 5-year Assets Average high stood at $257.3 million for Q1 2023, and its period low was $112.4 million during Q1 2021.
- Its 5-year average for Assets Average is $182.3 million, with a median of $189.8 million in 2022.
- Its Assets Average has fluctuated over the past 5 years, first surged by 7171.9% in 2022, then crashed by 4395.77% in 2024.
- Over the past 5 years, Therapeutics' Assets Average (Quarter) stood at $124.0 million in 2020, then skyrocketed by 67.82% to $208.0 million in 2021, then grew by 14.32% to $237.8 million in 2022, then dropped by 21.58% to $186.5 million in 2023, then crashed by 36.83% to $117.8 million in 2024.
- Its Assets Average stands at $117.8 million for Q3 2024, versus $141.5 million for Q2 2024 and $164.6 million for Q1 2024.